* iSpecimen Inc ISPC.OQ ISPC.O is expected to show a
rise in
quarterly revenue when it reports results on March 14.
* The Lexington Massachusetts-based company is expected to
report
a 4.9% increase in revenue to $2.675 million from $2.55 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for iSpecimen Inc is
for a
loss of 37 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for iSpecimen
Inc is
$8, above its last closing price of $1.42.
This summary was machine generated March 10 at 15:13 GMT. All
figures in US dollars unless otherwise stated